59
Views
2
CrossRef citations to date
0
Altmetric
INFECTIOUS DISEASE

Fungistatic effects of optical brightener 220 against Trichophyton tonsurans, Aspergillus fumigatus and Candida albicans

, , , , , , , , & show all
Pages 120-123 | Received 23 Dec 2009, Accepted 31 Aug 2009, Published online: 12 Jul 2009
 

Abstract

Background: Dermatophytes are one of the main causes of dermal infections. Moreover, there are some opportunistic fungi such as Aspergillus fumigatus (mycelial form) and Candida albicans (yeasty form) that in immunosuppressed patients can cause cutaneous disease. Objectives: The possible effect of optical brightener 220 (OB-220) on the growth of fungi has been evaluated in this study. Methods: Isolates were grown on agar plates containing OB-220 in concentration between 0.06 and 11.68 mg ml−1. MICs of OB-220, ketoconazole and fluconazole were obtained by the agar dilution method. Hyphae and yeasts grown with OB-220 were compared with controls by fluorescence and transmission electron microscopy. The cell cytotoxicity of OB-220 was also assessed. Results: The MIC90 of OB-220 was obtained: 1.17–1.46 mg ml−1 for A. fumigatus, 0.58–1.17 mg ml−1 for C. albicans and 0.29 mg ml−1 for Trichophyton tonsurans. Electron microscopy revealed a thickening and blurred contours of the cell wall by OB-220. OB-220 in concentrations up to 11.68 mg ml−1 posed no mammalian cell toxicity. Conclusion: OB-220 suppresses the growth of fungi by interfering with the formation of normal chitin.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.